Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cupric oxide (CuO) is an inorganic chemical compound that is widely investigated for its diverse applications, often in nanoparticle or thin film forms. It exhibits properties useful in photoelectrochemical water splitting, enhancing the formation of disinfection byproducts in water, and virucidal activity. As nanoparticles, it is explored for thermal therapy in lung tumors, antibacterial effects, and insecticidal activity. It also plays a role in material science for applications such as UV detection, solar-driven desalination, photocatalytic degradation, and glucose sensing. Furthermore, cupric oxide is recognized as a key nutrient involved in the pathophysiology of Age-related Macular Degeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cupric oxide.